Liver injury in Wilson's disease: An immunohistochemical study.
Copper
Liver fibrosis
Mitochondria
Wilson's disease
Journal
Advances in medical sciences
ISSN: 1898-4002
Titre abrégé: Adv Med Sci
Pays: Netherlands
ID NLM: 101276222
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
25
11
2021
revised:
04
03
2022
accepted:
16
04
2022
pubmed:
28
4
2022
medline:
26
10
2022
entrez:
27
4
2022
Statut:
ppublish
Résumé
Wilson's disease (WD) is an inherited disorder involving copper accumulation in the liver and brain. An important mechanism responsible for hepatocyte injury in WD is mitochondria destruction, although damage may also be caused by oxidative stress and lipid peroxidation. The study included 54 treated patients with WD without liver cirrhosis and 10 healthy controls. All patients had liver biopsy and immunohistochemical analysis of liver samples was performed using targeted staining for markers of mitochondrial injury (thioredoxin-2 [TRX2], cytochrome c oxidases subunit 2 [COX2], and cytochrome c oxidases complex IV subunit 4 isoform 1 [COX4-1]), of oxidative stress (peroxiredoxin-1 [PRDX1] and 8-hydroxyguanosine [8-OHdG]), and of lipid peroxidation (4-hydroxynonenal [4-HNE]). Expression, measured as mean strengths of intensity (SI) of immunohistochemical reactions per 5 fields of view, was significantly lower in patients with WD compared to controls for COX2 (2.9 vs 8.3), 8-OHdG (0.05 vs 3.8), TRX2 (4.9 vs 10.1), and PRDX1 (4.6 vs 10.1) (all P < 10 Negligible COX4-1 and low COX2 expression in liver specimens may serve as markers of inner mitochondrial membrane injury in treated patients with WD and early stages of liver fibrosis.
Identifiants
pubmed: 35477108
pii: S1896-1126(22)00017-7
doi: 10.1016/j.advms.2022.04.003
pii:
doi:
Substances chimiques
Copper
789U1901C5
Cyclooxygenase 2
EC 1.14.99.1
Cytochromes c
9007-43-6
Biomarkers
0
Oxidoreductases
EC 1.-
Peroxiredoxins
EC 1.11.1.15
Thioredoxins
52500-60-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
203-207Informations de copyright
Copyright © 2022 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare no conflict of interests.